ERLOTINIB AS SECOND-LINE TREATMENT FOR PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER AND NON-SQUAMOUS HISTOLOGY: A GALICIAN LUNG CANCER GROUP STUDY (GGCP041/09)

被引：0
|
作者：
Vazquez, S. [1 ]
Casal, Joaquin [2 ]
Firvida, J. L. [3 ]
Lazaro, Martin [2 ]
Varela, S. [1 ]
Jose Villanueva, Maria [2 ]
Garcia-Lopez, Jesus [3 ]
Campos, Begona [1 ]
Grande, C. [2 ]
Fernandez, Ovidio [3 ]
机构：
[1] Hosp Univ Lucus Augusti, Lugo, Spain
[2] Complexo Hosp Univ, Pontevedra, Spain
[3] Complexo Hosp Ourense, Med Oncol Serv, Orense, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
Non-Small-Cell Lung Cancer; EGFR-TKI; Non-squamous histology;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1297 / S1297
页数：1
相关论文
共 50 条
  • [11] Treatment Monitoring Program for Implementation of Adherence to Second-Line Erlotinib for Advanced Non-Small-Cell Lung Cancer
    Gebbia, Vittorio
    Bellavia, Massimo
    Banna, Giuseppe Luigi
    Russo, Paolo
    Ferrau, Francesco
    Tralongo, Paolo
    Borsellino, Nicolo
    CLINICAL LUNG CANCER, 2013, 14 (04) : 390 - 398
  • [12] Second-line therapy for advanced non-small-cell lung cancer
    Hann C.L.
    Brahmer J.R.
    Current Oncology Reports, 2006, 8 (4) : 243 - 247
  • [13] Nivolumab for second-line treatment of metastatic squamous non-small-cell lung cancer
    Rounds, Amanda
    Kolesar, Jill
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (21) : 1851 - 1855
  • [14] Pemetrexed in maintenance treatment of advanced non-squamous non-small-cell lung cancer
    Minami, Seigo
    Kijima, Takashi
    LUNG CANCER-TARGETS AND THERAPY, 2015, 6 : 13 - 25
  • [15] Efficiency of nivolumab in the treatment of second-line advanced non-squamous non-small cell lung cancer (NSCLC) in Spain
    Gonzalez, P.
    Ortega-Joaquin, N.
    Provencio Pulla, M.
    Garrido, C.
    Echave, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [16] Biweekly paclitaxel as second-line treatment in advanced non-small-cell-lung-cancer (NSCLC).: A phase II study of the Galician Lung Cancer Group
    Vazquez-Estevez, S.
    Firvida, J. L.
    Grande, C.
    Baron, F.
    Lazaro, M.
    Salgado, M.
    Campos, B.
    Casal, J.
    Perez, E.
    Mel, J. R.
    EJC SUPPLEMENTS, 2007, 5 (04): : 392 - 392
  • [17] Nivolumab in Second-Line Treatment for Advanced Non-Small-Cell Lung Cancer With Squamous-Cell Histology: A Perspective Based on Pharmacologic Costs
    Giuliani, Jacopo
    Bonetti, Andrea
    CLINICAL LUNG CANCER, 2017, 18 (05) : E363 - E365
  • [18] Efficacy and Safety of Pemetrexed-Cisplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer - a Galician Lung Cancer Group Study
    Senin, C.
    Varela, S.
    Huidobro, G.
    Firvida, J. L.
    Baron, F.
    Amenedo, M.
    Afonso, F. J.
    Lazaro, M.
    Campos, B.
    Casal, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S624 - S624
  • [19] TOLERANCE AND EFFICACY OF PEMETREXED-CISPLATIN FOR ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER A GALICIAN LUNG CANCER GROUP STUDY
    Senin, Clara
    Campos, Begona
    Jose Villanueva, Maria
    Firvida, J. L.
    Baron, Francisco
    Amenedo, Margarita
    Afonso, Javier
    Lazaro, Martin
    Varela, S.
    Grande, C.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1277 - S1277
  • [20] Prolgolimab with chemotherapy as first-line treatment for advanced non-squamous non-small-cell lung cancer
    Laktionov, K.
    Smolin, A.
    Stroyakovskiy, D.
    Moiseenko, V.
    Dvorkin, M.
    Andabekov, T.
    Cheng, Y.
    Liu, B.
    Kozlov, V.
    Odintsova, S.
    Dvoretsky, S.
    Mochalova, A.
    Urda, M.
    Yi, T.
    Li, X.
    Laszlo, U.
    Mueller, V.
    Bogos, K.
    Fadeeva, N.
    Musaev, G.
    Liu, Q.
    Kirtbaya, D.
    Shi, J.
    Gladkov, O.
    Narimanov, M.
    Semiglazova, T.
    Khasanova, A.
    Chovanec, J.
    Andrasina, I
    Szabova, A.
    Rosinska, O.
    Sudekova, D.
    Zsolt, P. -s.
    Ran, F.
    Sun, M.
    Jiang, O.
    Chen, R.
    Zhao, E.
    Liu, C.
    Tan, W.
    Pirmagomedov, A.
    Poddubskaya, E.
    Kislov, N.
    Shumskaya, I.
    Sorokina, I.
    Zinkina-Orikhan, A.
    Linkova, Yu.
    Fogt, S.
    Liaptseva, D.
    Siliutina, A.
    EUROPEAN JOURNAL OF CANCER, 2025, 217
12345